Vaxart Inc. (VXRT): Price and Financial Metrics

VXRT POWR Grades

• VXRT scores best on the Value dimension, with a Value rank ahead of 40.39% of US stocks.
• VXRT's strongest trending metric is Growth; it's been moving up over the last 179 days.
• VXRT's current lowest rank is in the Stability metric (where it is better than 3.48% of US stocks).

VXRT Stock Summary

• Vaxart Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than merely 6.54% of US listed stocks.
• With a price/sales ratio of 737.66, Vaxart Inc has a higher such ratio than 99.38% of stocks in our set.
• Revenue growth over the past 12 months for Vaxart Inc comes in at -77.95%, a number that bests only 1.46% of the US stocks we're tracking.
• If you're looking for stocks that are quantitatively similar to Vaxart Inc, a group of peers worth examining would be CLDX, LXRX, ADAP, CAPR, and FUSN.
• VXRT's SEC filings can be seen here. And to visit Vaxart Inc's official web site, go to vaxart.com.

VXRT Valuation Summary

• VXRT's price/earnings ratio is -20.3; this is 155.62% lower than that of the median Healthcare stock.
• Over the past 243 months, VXRT's price/earnings ratio has gone down 77.5.
• VXRT's EV/EBIT ratio has moved down 67.6 over the prior 243 months.

Below are key valuation metrics over time for VXRT.

VXRT Growth Metrics

The 4 year net income to common stockholders growth rate now stands at 51.3%.
• Its 2 year cash and equivalents growth rate is now at 70.67%.
• Its 4 year cash and equivalents growth rate is now at -2.42%.

VXRT's revenue has moved down $8,008,000 over the prior 52 months.

The table below shows VXRT's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-12-31	0.892	-59.832	-70.47
2021-09-30	1.174	-54.784	-63.567
2021-06-30	1.239	-49.772	-54.069
2021-03-31	1.65	-37.134	-46.93
2020-12-31	4.046	-23.75	-32.22
2020-09-30	7.606	-16.776	-24.768

VXRT's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• VXRT has a Quality Grade of D, ranking ahead of 8.43% of graded US stocks.
• VXRT's asset turnover comes in at 0.007 -- ranking 401st of 680 Pharmaceutical Products stocks.
• ABEO, BCDA, and PCRX are the stocks whose asset turnover ratios are most correlated with VXRT.

The table below shows VXRT's key quality metrics over time.